Finance
Are BioDelivery Sciences International Inc. (NASDAQ:BDSI) Prospects Worsening?
BioDelivery Sciences International Inc. (NASDAQ:BDSI) has a beta of 0.72, a 12-month trailing P/E ratio of 14.63, and a growth ratio of 0.59. The stock’s
BioDelivery Sciences International Inc. (NASDAQ:BDSI) has a beta of 0.72, a 12-month trailing P/E ratio of 14.63, and a growth ratio of 0.59. The stock’s
BioDelivery Sciences International Inc. (NASDAQ:BDSI) shares fell to a low of $3.64 before closing at $3.67. Intraday shares traded counted 0.55 million, which was 43.18%
BioDelivery Sciences International Inc. (NASDAQ:BDSI) shares fell to a low of $3.55 before closing at $3.62. Intraday shares traded counted 0.42 million, which was 58.79%
BioDelivery Sciences International Inc. (NASDAQ:BDSI) has a beta of 0.70, a 12-month trailing P/E ratio of 14.27, and a growth ratio of 0.57. The stock’s
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne